113 related articles for article (PubMed ID: 32932279)
1. LifePearl microspheres loaded with irinotecan in the treatment of Liver-dominant metastatic colorectal carcinoma: feasibility, safety and pharmacokinetic study.
Maleux G; Prenen H; Helmberger T; Spriet I; Isailovic TV; Pereira P
Anticancer Drugs; 2020 Nov; 31(10):1084-1090. PubMed ID: 32932279
[TBL] [Abstract][Full Text] [Related]
2. Irinotecan-Eluting 75-150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study.
Fereydooni A; Letzen B; Ghani MA; Miszczuk MA; Huber S; Chapiro J; Schlachter T; Geschwind JF; Georgiades C
J Vasc Interv Radiol; 2018 Dec; 29(12):1646-1653.e5. PubMed ID: 30337148
[TBL] [Abstract][Full Text] [Related]
3. Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
Tanaka T; Sato T; Nishiofuku H; Masada T; Tatsumoto S; Marugami N; Otsuji T; Kanno M; Koyama F; Sho M; Kichikawa K
BMC Cancer; 2019 Aug; 19(1):758. PubMed ID: 31370815
[TBL] [Abstract][Full Text] [Related]
4. Transarterial Embolization with Small-Size Particles Loaded with Irinotecan for the Treatment of Colorectal Liver Metastases: Results of the MIRACLE III Study.
Mauri G; Varano GM; Della Vigna P; Bonomo G; Monfardini L; Zampino MG; Ravenda PS; Orsi F
Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1708-1715. PubMed ID: 29951693
[TBL] [Abstract][Full Text] [Related]
5. First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI).
Eichler K; Zangos S; Mack MG; Hammerstingl R; Gruber-Rouh T; Gallus C; Vogl TJ
Int J Oncol; 2012 Oct; 41(4):1213-20. PubMed ID: 22842404
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL.
Pereira PL; Arnold D; de Baère T; Gomez F; Helmberger T; Iezzi R; Maleux G; Prenen H; Sangro B; Nordlund A; Zeka B; Bauer R; Kaufmann N; Pellerin O; Taieb J
Dig Liver Dis; 2020 Aug; 52(8):857-861. PubMed ID: 32620520
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.
Martin RC; Robbins K; Tomalty D; O'Hara R; Bosnjakovic P; Padr R; Rocek M; Slauf F; Scupchenko A; Tatum C
World J Surg Oncol; 2009 Nov; 7():80. PubMed ID: 19886993
[TBL] [Abstract][Full Text] [Related]
8. Prospective Series of Transarterial Chemoembolization of Metastatic Colorectal Cancer to the Liver with 30-60 μm Microspheres Loaded with Irinotecan.
Malagari K; Kiakidis T; Moschouris H; Charokopakis A; Vergadis C; Alevisopoulos N; Kartsouni V; Panagiotou I; Pellerin O; Glantzounis G; Filippiadis DK; Emmanouil E; Tsavaris N; Psarros G; Delicha E; Kelekis N
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):880-890. PubMed ID: 37337059
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and Safety of CT-Guided High-Dose-Rate Brachytherapy Combined with Transarterial Chemoembolization Using Irinotecan-Loaded Microspheres for the Treatment of Large, Unresectable Colorectal Liver Metastases.
Collettini F; Jonczyk M; Meddeb A; Wieners G; Geisel D; Schnapauff D; Gebauer B
J Vasc Interv Radiol; 2020 Feb; 31(2):315-322. PubMed ID: 31537409
[TBL] [Abstract][Full Text] [Related]
10. Complications Following Irinotecan-Loaded Microsphere Chemoembolization of Colorectal Metastatic Liver Lesions Associated with Hepatic-Artery Branch Temporary Stasis.
Szemitko M; Golubinska-Szemitko E; Sienko J; Falkowski A
Curr Oncol; 2021 Jun; 28(3):2296-2307. PubMed ID: 34203031
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
Bhutiani N; Akinwande O; Martin RC
World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
[TBL] [Abstract][Full Text] [Related]
12. DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.
Di Noia V; Basso M; Marsico V; Cerchiaro E; Rossi S; D'Argento E; Strippoli A; Schinzari G; Iezzi R; Cassano A; Barone C
Future Oncol; 2019 Jul; 15(20):2349-2360. PubMed ID: 28440086
[No Abstract] [Full Text] [Related]
13. A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver.
Melancon MP; Yevich S; Avritscher R; Swigost A; Lu L; Tian L; Damasco JA; Dixon K; Cortes AC; Munoz NM; Liang D; Liu D; Tam AL
Drug Deliv; 2021 Dec; 28(1):240-251. PubMed ID: 33501859
[TBL] [Abstract][Full Text] [Related]
14. Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.
Iezzi R; Marsico VA; Guerra A; Cerchiaro E; Cassano A; Basso M; Devicienti E; Rodolfino E; Barone C; Bonomo L
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1523-31. PubMed ID: 25799948
[TBL] [Abstract][Full Text] [Related]
15. Small-size (40 µm) Beads Loaded with Irinotecan in the Treatment of Patients with Colorectal Liver Metastases.
Mauri G; Rossi D; Frassoni S; Bonomo G; Camisassi N; Della Vigna P; Bagnardi V; Maiettini D; Varano GM; Zampino MG; Orsi F
Cardiovasc Intervent Radiol; 2022 Jun; 45(6):770-779. PubMed ID: 35029709
[TBL] [Abstract][Full Text] [Related]
16. An in-vitro evaluation of three types of drug-eluting microspheres loaded with irinotecan.
Pereira PL; Plotkin S; Yu R; Sutter A; Wu Y; Sommer CM; Cruise GM
Anticancer Drugs; 2016 Oct; 27(9):873-8. PubMed ID: 27416270
[TBL] [Abstract][Full Text] [Related]
17. Early Experience with 70-150 μm Irinotecan Drug-eluting Beads (M1-DEBIRI) for the Treatment of Unresectable Hepatic Colorectal Metastases.
Akinwande O; Scoggins C; Martin RC
Anticancer Res; 2016 Jul; 36(7):3413-8. PubMed ID: 27354601
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and antitumor efficacy of chemoembolization using 40 µm irinotecan-loaded microspheres in a rabbit liver tumor model.
Tanaka T; Nishiofuku H; Hukuoka Y; Sato T; Masada T; Takano M; Gilbert CW; Obayashi C; Kichikawa K
J Vasc Interv Radiol; 2014 Jul; 25(7):1037-1044.e2. PubMed ID: 24861663
[TBL] [Abstract][Full Text] [Related]
19. Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study.
Aliberti C; Fiorentini G; Muzzio PC; Pomerri F; Tilli M; Dallara S; Benea G
Anticancer Res; 2011 Dec; 31(12):4581-7. PubMed ID: 22199334
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
Narayanan G; Barbery K; Suthar R; Guerrero G; Arora G
Anticancer Res; 2013 May; 33(5):2077-83. PubMed ID: 23645758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
